High-risk MVI (M2) is often associated with activation of epithelial-mesenchymal transition (EMT), involving downregulation of E-cadherin and upregulation of N-cadherin and vimentin, which enhances tumor cell migration and invasiveness (27, 28). Here, CDH2 is linked to neoplasm.